BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27069140)

  • 1. NFκB-Associated Pathways in Progression of Chemoresistance to 5-Fluorouracil in an In Vitro Model of Colonic Carcinoma.
    Körber MI; Staribacher A; Ratzenböck I; Steger G; Mader RM
    Anticancer Res; 2016 Apr; 36(4):1631-9. PubMed ID: 27069140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.
    Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M
    Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells.
    Zhu Y; Yu J; Wang S; Lu R; Wu J; Jiang B
    Oncol Rep; 2014 Dec; 32(6):2437-44. PubMed ID: 25230779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells.
    Kodach LL; Bos CL; Durán N; Peppelenbosch MP; Ferreira CV; Hardwick JC
    Carcinogenesis; 2006 Mar; 27(3):508-16. PubMed ID: 16344270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer.
    Voboril R; Hochwald SN; Li J; Brank A; Weberova J; Wessels F; Moldawer LL; Camp ER; MacKay SL
    J Surg Res; 2004 Aug; 120(2):178-88. PubMed ID: 15234211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin induces chemoresistance in colon cancer cells through activation of the PI3K/Akt/survivin pathway.
    Xiao ZM; Wang XY; Wang AM
    Biotechnol Appl Biochem; 2015; 62(3):401-6. PubMed ID: 24372557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability.
    Juan HC; Tsai HT; Chang PH; Huang CY; Hu CP; Wong FH
    Apoptosis; 2011 Feb; 16(2):174-83. PubMed ID: 21082354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells.
    Zhao Y; Shen S; Guo J; Chen H; Greenblatt DY; Kleeff J; Liao Q; Chen G; Friess H; Leung PS
    J Surg Res; 2006 Dec; 136(2):325-35. PubMed ID: 17054996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance.
    Chen YY; Wang ZX; Chang PA; Li JJ; Pan F; Yang L; Bian ZH; Zou L; He JM; Liang HJ
    Cancer Sci; 2009 Sep; 100(9):1708-13. PubMed ID: 19500106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation.
    Fu J; Xu Y; Yang Y; Liu Y; Ma L; Zhang Y
    Sci Rep; 2019 Nov; 9(1):16937. PubMed ID: 31729451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between the TNF and IGF pathways enhances NF-κB activation and signaling in cancer cells.
    Li S; Pinard M; Wang Y; Yang L; Lin R; Hiscott J; Su B; Brodt P
    Growth Horm IGF Res; 2015 Oct; 25(5):253-61. PubMed ID: 26239406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells.
    Hoshiba T; Tanaka M
    Biochim Biophys Acta; 2016 Nov; 1863(11):2749-2757. PubMed ID: 27558478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells.
    Lv L; Liu HG; Dong SY; Yang F; Wang QX; Guo GL; Pan YF; Zhang XH
    Tumour Biol; 2016 Jul; 37(7):8811-24. PubMed ID: 26747179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-kappaB signaling pathway in colorectal carcinomas.
    Chen Y; Wang Z; Chang P; Xiang L; Pan F; Li J; Jiang J; Zou L; Yang L; Bian Z; Liang H
    Int J Cancer; 2010 Jul; 127(1):195-206. PubMed ID: 19904749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
    Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model.
    Körber MI; Klingenbrunner S; Bartsch R; Steger GG; Mader RM
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):35-7. PubMed ID: 23259994
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil.
    Vinod BS; Antony J; Nair HH; Puliyappadamba VT; Saikia M; Narayanan SS; Bevin A; Anto RJ
    Cell Death Dis; 2013 Feb; 4(2):e505. PubMed ID: 23429291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
    Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
    Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells.
    Fukuyama R; Ng KP; Cicek M; Kelleher C; Niculaita R; Casey G; Sizemore N
    Mol Carcinog; 2007 May; 46(5):402-13. PubMed ID: 17186550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.